Literature DB >> 19634118

What do pregnant women know about non-steroidal anti-inflammatory drugs?

Christine Damase-Michel1, Julie Christaud, Alain Berrebi, Isabelle Lacroix, Jean-Louis Montastruc.   

Abstract

OBJECTIVE: Non-steroidal anti-inflammatory drug (NSAID) use on late pregnancy can be associated with severe adverse neonatal outcomes. Some NSAIDs, available over the counter, can be purchased easily by pregnant women. The present study evaluates pregnant womens' knowledge about NSAID use in pregnancy. STUDY
DESIGN: The survey includes 250 pregnant women in South-west France. Women have been interviewed about their knowledge on analgesic and NSAID use in pregnancy.
RESULTS: A total of 2% pregnant women use aspirin or ibuprofen as self-medication. More than 10% of the women think that it is safe to take NSAIDs on late pregnancy. A majority of them thought that aspirin and ibuprofen are not NSAIDs.
CONCLUSION: NSAID risks in pregnancy are insufficiently known. Adequate information must be provided not only to medical practitioners and pharmacists but also to pregnant women especially for drugs which are available over the counter. (c) 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634118     DOI: 10.1002/pds.1817

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Drug prescribing before and during pregnancy in south west France: a retrolective study.

Authors:  Sophie Crespin; Robert Bourrel; Caroline Hurault-Delarue; Maryse Lapeyre-Mestre; Jean-Louis Montastruc; Christine Damase-Michel
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

Review 2.  Medication management during pregnancy: role of the pharmacist.

Authors:  Nardin Samuel; Adrienne Einarson
Journal:  Int J Clin Pharm       Date:  2011-12

3.  Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study.

Authors:  K Nezvalová-Henriksen; O Spigset; H Nordeng
Journal:  BJOG       Date:  2013-03-14       Impact factor: 6.531

4.  Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists.

Authors:  Molly M Lynch; Jacqueline B Amoozegar; Emily M McClure; Linda B Squiers; Cheryl S Broussard; Jennifer N Lind; Kara N Polen; Meghan T Frey; Suzanne M Gilboa; Janis Biermann
Journal:  Qual Health Res       Date:  2017-10-03

5.  Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study.

Authors:  Marleen M H J van Gelder; Nel Roeleveld; Hedvig Nordeng
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

6.  Pregnant women and non-steroidal anti-inflammatory drugs: knowledge, perception and drug consumption pattern during pregnancy in ethiopia.

Authors:  Chalelgn Kassaw; Nasir Tajure Wabe
Journal:  N Am J Med Sci       Date:  2012-02

7.  Impacts of counseling on knowledge, attitude and practice of medication use during pregnancy.

Authors:  Ramesh Devkota; G M Khan; Kadir Alam; Binaya Sapkota; Deepa Devkota
Journal:  BMC Pregnancy Childbirth       Date:  2017-04-27       Impact factor: 3.007

8.  Epidural analgesia for the treatment of colic attack with retrocaval ureter in late pregnancy complicated with marginal placenta previa: a case report.

Authors:  Soshi Iwasaki; Kohsuke Hamada; Kazunobu Takahashi; Mika Takahashi; Eri Mizuno; Naomi Mizukami; Michiaki Yamakage
Journal:  JA Clin Rep       Date:  2019-08-14

9.  Ibuprofen results in alterations of human fetal testis development.

Authors:  Millissia Ben Maamar; Laurianne Lesné; Kristin Hennig; Christèle Desdoits-Lethimonier; Karen R Kilcoyne; Isabelle Coiffec; Antoine D Rolland; Cécile Chevrier; David M Kristensen; Vincent Lavoué; Jean-Philippe Antignac; Bruno Le Bizec; Nathalie Dejucq-Rainsford; Rod T Mitchell; Séverine Mazaud-Guittot; Bernard Jégou
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

10.  Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.

Authors:  Manon Cairat; Marie Al Rahmoun; Marc J Gunter; Gianluca Severi; Laure Dossus; Agnès Fournier
Journal:  Breast Cancer Res       Date:  2020-10-31       Impact factor: 6.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.